Elizabeth Calleja

Elizabeth Calleja has over 20 years of work experience in the healthcare industry. Elizabeth began their career in 1998 as an Instructor at Memorial Sloan-Kettering Cancer Center, where they worked until 2001. During this time, they also served as a Consultant.

In 2001, Calleja joined Roche as a Clinical Director, a position they held for over 16 years. In this role, they contributed to the development of clinical trials and oversaw medical research projects.

In 2017, Calleja transitioned to Taiho Oncology, Inc. as a Senior Medical Director until 2019. Elizabeth then advanced to the position of Vice President of Clinical Development in January 2020, where they continue to contribute their expertise in clinical research and development.

Throughout their career, Calleja has demonstrated a strong commitment to advancing oncology research and improving patient outcomes.

Elizabeth Calleja attended Georgetown University School of Medicine from 1985 to 1989. Elizabeth obtained their MD degree in the field of Medicine during that time.